University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Kenneth Woeber, M.D.

Endocrinologist

Dr. Kenneth A. Woeber is an endocrinologist who sees patients in the Endocrinology Clinic at the Mount Zion campus and Thyroid Clinic at the Parnassus campus of UCSF Medical Center. He is certified by the American Board of Internal Medicine in endocrinology and metabolism and is a fellow of the Royal College of Physicians of Edinburgh.

A native of South Africa, he earned undergraduate and medical degrees at the University of the Witwatersrand. He went to the Harvard Medical Unit and Thorndike Memorial Laboratory for postgraduate training, later serving on the faculty at Harvard Medical School. His research addresses the transport and peripheral metabolism of thyroid hormone. He received the Van Meter Prize of the American Thyroid Association and served as chair of the subspecialty board of Endocrinology and Metabolism of the American Board of Internal Medicine. At UCSF, Woeber is a professor of medicine, an honorary member of Alpha Omega Alpha and a master cllinician in the Department of Medicine.

Clinics

Endocrinology Clinic at Mount Zion
2200 Post St., Suite C-432
San Francisco, CA 94115
Phone: (415) 885–7574
Fax: (415) 885–7724

Hours: Monday to Friday, 8:30 a.m. – 5 p.m.

Thyroid Clinic
400 Parnassus Ave., Suite A-550
San Francisco, CA 94143
Phone: (415) 353–2350
Fax: (415) 353–2337

Hours: Monday to Friday, 8 a.m. – 4:30 p.m.

Conditions & Treatments

More about Kenneth Woeber

Education

University of Witwatersrand School of Medicine 1957

Residencies

Johannesburg Hospital 1959

Fellowships

Harvard Medical Unit, Boston City Hospital, Endocrinology 1962

Selected Research and Publications

  1. Cascino MD, McNabb B, Gardner DG, Woeber KA, Fox AN, Wang B, Fix OK. Acute liver failure with thyrotoxicosis treated with liver transplantation. Endocr Pract. 2013 May-Jun; 19(3):e57-60.
  2. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012 Dec; 22(12):1200-35.
  3. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012 Nov-Dec; 18(6):988-1028.
  4. Moalem J, Choi DX, Khanafshar E, Ruan DT, Woeber KA, Clark OH, Kebebew E. Metastatic papillary thyroid cancer misdiagnosed as non-small [corrected] cell lung cancer. Thyroid. 2011 Mar; 21(3):319-23.
  5. Woeber KA. Relationship between thyroid stimulating hormone and thyroid stimulating immunoglobulin in Graves' hyperthyroidism. J Endocrinol Invest. 2011 Mar; 34(3):222-4.
  6. Kebebew E, Lindsay S, Clark OH, Woeber KA, Hawkins R, Greenspan FS. Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer. Thyroid. 2009 Sep; 19(9):953-6.
  7. Woeber KA, Schwartz LK. Graves ophthalmopathy after radiation treatment of thyroid cancer. Endocr Pract. 2008 May-Jun; 14(4):419-21.
  8. Kebebew E, Peng M, Reiff E, Treseler P, Woeber KA, Clark OH, Greenspan FS, Lindsay S, Duh QY, Morita E. A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. Surgery. 2006 Dec; 140(6):960-6; discussion 966-7.
  9. Woeber KA. Triiodothyronine production in Graves' hyperthyroidism. Thyroid. 2006 Jul; 16(7):687-90.
  10. Woeber KA. Observations concerning the natural history of subclinical hyperthyroidism. Thyroid. 2005 Jul; 15(7):687-91.
  11. Kebebew E, Greenspan FS, Clark OH, Woeber KA, Grunwell J. Extent of disease and practice patterns for medullary thyroid cancer. J Am Coll Surg. 2005 Jun; 200(6):890-6.
  12. Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005 Apr 1; 103(7):1330-5.
  13. Rushakoff RJ, Woeber KA. Evaluation of a "formal" endocrinology curbside consultation service: advice by means of internet, fax, and telephone. Endocr Pract. 2003 Mar-Apr; 9(2):124-7.
  14. Woeber KA. Methimazole-induced hepatotoxicity. Endocr Pract. 2002 May-Jun; 8(3):222-4.
  15. Woeber KA. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest. 2002 Feb; 25(2):106-9.
  16. Woeber KA. Update on the management of hyperthyroidism and hypothyroidism. Arch Fam Med. 2000 Aug; 9(8):743-7.
  17. Woeber KA. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med. 2000 Apr 24; 160(8):1067-71.
  18. Woeber KA. The year in review: the thyroid. Ann Intern Med. 1999 Dec 21; 131(12):959-62.
  19. Woeber KA, Warner I. Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis. West J Med. 1999 Jan; 170(1):49-51.
  20. Woeber KA. Subclinical thyroid dysfunction. Arch Intern Med. 1997 May 26; 157(10):1065-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.